Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal RANBP2 Primary Antibody for IP, WB - ABIN408616
Wang, Yan, Liu, Liu, Lin, Liu, Chen, Zhang, Xu, Shi, Li, Zhao, Meng, Xia, Li, Zhu: HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells. in Nature communications 2017
Cow (Bovine) Polyclonal RANBP2 Primary Antibody for IHC (p), IHC - ABIN266970
Hamard, Boyer-Guittaut, Camuzeaux, Dujardin, Hauss, Oelgeschläger, Vigneron, Kedinger, Chatton: Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity. in Nucleic acids research 2007
Human Polyclonal RANBP2 Primary Antibody for ICC, IF - ABIN3201003
Yokoyama, Hayashi, Seki, Panté, Ohba, Nishii, Kuma, Hayashida, Miyata, Aebi: A giant nucleopore protein that binds Ran/TC4. in Nature 1995
We describe three in vitro reconstituted disassembly intermediates, which show binding of a Crm1 (show XPO1 Antibodies) export complex via two FG-repeat patches, cargo-release by RanBP2's Ran-binding domains and retention of free Crm1 (show XPO1 Antibodies) at RanBP2 after Ran-GTP (show AK3 Antibodies) hydrolysis.
RAN binding protein 2 increase the sumoylation of cyclin-dependent kinase inhibitor 1B (show CDKN1B Antibodies) in cholangiocarcinoma cell line QBC939.
Importin-beta (show KPNB1 Antibodies) and CRM1 (show XPO1 Antibodies) control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
Translocation of p53 (show TP53 Antibodies) is regulated by androgen-dependent sumoylation mediated by the G3BP2 (show G3BP2 Antibodies)-interacting SUMO-E3 ligase (show PIAS1 Antibodies), RanBP2. G3BP2 (show G3BP2 Antibodies) knockdown results in reduced tumor growth and increased nuclear p53 (show TP53 Antibodies) accumulation in mouse xenograft models of prostate cancer with or without long-term androgen deprivation.
These our results reveal spatio-temporal regulation in the recruitment of nucleoporins and translation factors to cytoplasmic viral factories , and particularly the importance of Nup358 in vaccinia virus infection.
NUSAP1 (show NUSAP1 Antibodies) contributes to accurate chromosome segregation by acting as a co-factor for RanBP2-RanGAP1 (show RANGAP1 Antibodies)-UBC9 (show UBE2I Antibodies) during cell division.
Nup358-AGO interaction is important for miRNA-mediated gene silencing and identifies SIM (show SIM2 Antibodies) as a new interacting motif for the AGO family of proteins.
recurrent or familial ANE without the RANBP2 mutation has a more severe outcome and greater predilection for male sex than that with the RANBP2 mutation. This suggests that there are unknown gene mutations linked to ANE.
Based on the literature review of ANE1 with RANBP2 mutation, we propose a threshold for RANBP2 mutation tes (show TES Antibodies)
findings indicate that RanGDP and not RanGTP is the physiological target for the RanBP2 SUMO E3 ligase (show PIAS1 Antibodies) complex
These results demonstrate a function of RanBP2-mediated SUMOylation of SHP (show LAMC1 Antibodies) in maintaining bile acids (BA) homoeostasis and protecting from the BA hepatotoxicity.
results demonstrate that Ranbp2 controls nucleocytoplasmic, chemokine and metalloproteinase 28 signaling, and proteostasis of substrates that are crucial to motoneuronal homeostasis and whose impairments by loss of Ranbp2 drive ALS-like syndromes
RanBP2 expression was regulated by Zap70 (show ZAP70 Antibodies).
Data (including data from studies in transgenic/knockout mice) suggest that Ranbp2 in photoreceptor neurons participates in coupling of photoreceptor degeneration (neural dysmorphology) and apoptosis (neural death) caused by toxic exposure to light.
These studies unravel selective roles of Ranbp2 and its RBD2 and RBD3 in retinal pigment epithelium survival and functions.
These results unveil distinct mechanistic and biological links between prolyl isomerase and chaperone activities of Ranbp2 cyclophilin (show PPIE Antibodies) toward proteostasis.
Novel roles in Ran GTPase (show RAN Antibodies)-independent subdomains of RBD2 and RBD3, and KBD of RanBP2, confer antagonizing and multi-modal mechanisms of kinesin-1 activation and regulation of mitochondrial motility.
Ranbp2 haploinsufficiency is associated with metabolic imbalances leading to parkinson's disease.
Knockdown of RANBP2 specifically affected the late step of nuclear entry, inducing cytoplasmic granules enriched with phosphorylated components. This suggests a novel regulatory mechanism for nuclear speckle formation involving RANBP2 and phosphorylation.
A critical function of RanBP2 is to capture recycling RanGTP-importin-beta (show KPNB1 Antibodies) complexes at cytoplasmic fibrils to allow for adequate classical nuclear localization signal-mediated cargo import.
reports identification of the cyclophilin-related protein (show PPID Antibodies), RanBP2 (note at the time the protein was not designated RanBP2), and the cis (show CISH Antibodies)-trans prolyl isomerase activity of its cyclophilin (show PPIE Antibodies) domain
reports interaction of the RBD4 and CY domains of RanBP2 with red/green opsin (show OPN1MW Antibodies) and the chaperone activity of these domains toward red/green opsin (show OPN1MW Antibodies).
reports identification of a binding domain in RanBP2, the cyclophilin (show PPIE Antibodies)-like domain, toward components of the 19S cap of the proteasome
reports identification of a binding domain in RanBP2, the zinc-finger rich domain, toward CRM1/exportin-1 (show XPO1 Antibodies)
reports identification of a novel domain in RanBP2 located between RBD2 and RBD3 with specific binding activity against the conventional heavy chain kinesins, KIF5B (show KIF5B Antibodies) and KIF5C (show KIF5C Antibodies)
reports the novel subcellular localizations of RanBP2 in retinal neurons of human and bovine
the cyclophilin-like domain of Ran-binding protein-2 modulates selectively the activity of the ubiquitin-proteasome system and protein biogenesis
RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q.
358 kDa nucleoporin
, E3 SUMO-protein ligase RanBP2
, nuclear pore complex protein Nup358
, nucleoporin 358
, nucleoporin Nup358
, ran-binding protein 2
, transformation-related protein 2
, RAN binding protein 2
, e3 SUMO-protein ligase RanBP2-like